Mirae Asset Global Investments Co., Ltd. Centessa Pharmaceuticals PLC Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,972 shares of CNTA stock, worth $49,424. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,972
Previous 2,556
16.28%
Holding current value
$49,424
Previous $40,000
22.5%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding CNTA
# of Institutions
118Shares Held
124MCall Options Held
7KPut Options Held
220K-
Medicxi Ventures Management (Jersey) LTD20MShares$332 Million73.44% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$166 Million99.89% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$161 Million5.81% of portfolio
-
Perceptive Advisors LLC New York, NY6.35MShares$106 Million3.55% of portfolio
-
First Light Asset Management, LLC Edina, MN5.81MShares$96.5 Million9.51% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.57B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...